Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PERIMARK - DKK3 as a Biomarker of Peritoneal Fibrosis in Peritoneal Dialysis Patients: A Prospective, Monocentric, Exploratory Longitudinal Study With Biobanking

NCT07806708 is registered in ClinicalTrials.gov with Universität des Saarlandes as lead sponsor.

NCT NCT07806708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07806708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PERIMARK - DKK3 as a Biomarker of Peritoneal Fibrosis in Peritoneal Dialysis Patients: A Prospective, Monocentric, Exploratory Longitudinal Study With Biobanking
Lead sponsor
Universität des Saarlandes
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
June 1, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease (esrd), peritoneal dialysis (pd), peritoneal fibrosis, ultrafiltration failure